Flibanserin (FLB) was approved by FDA for the treatment of pre-menopausal female
hypoactive sexual desire disorder (HSDD). FLB suffers from low oral bioavailability (33%) …

Flibanserin (FLB) is a nonhormonal medicine approved by the Food and Drug
Administration (FDA) to treat the hypoactive sexual appetite disorder in females. However …

Flibanserin (FLB) is a multifunctional serotonergic agent that was recently approved by the
FDA for the oral treatment of premenopausal women with hypoactive sexual desire disorder …

Background and Aim Flibanserin (FLB) is a multifunctional serotonergic agent used for
treating hypoactive sexual desire disorder in premenopausal women via oral administration …

Flibanserin was licensed by the United States Food and Drug Administration (FDA) as an
oral non-hormonal therapy for pre-menopausal women with inhibited sexual desire disorder …

In this study, liquid crystalline nanoparticles (LCN) have been proposed as new carrier for
topical delivery of finasteride (FNS) in the treatment of androgenetic alopecia. To evaluate …

Hirsutism is a dermatological condition that refers to the excessive growth of hair in
androgen-sensitive areas in women. Recently, the enhancement of the visible signs of a …

The current study is regarding the development and characterization of Darifenacin-loaded
self-assembled liquid crystal cubic nanoparticles (LCCN). An anhydrous approach was used …

Purpose The present work seeks to develop, assess and refine a nanoethosomal vaginal in
situ gel containing Berberine, aimed at enhancing its efficacy in treating Poly Cystic Ovary …

Context: Flutamide is a potent anti-androgen with the several unwanted side effects in
systemic administration, therefore, it has attracted special interest in the development of …